Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury (NACAM) Trial

NCT04750616 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT04750616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04750616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury (NACAM) Trial
Lead sponsor
Kaiser Permanente
Phase
Phase 2
Overall status
Recruiting
Start date
September 13, 2021
Completion date
June 30, 2025
Enrollment
304 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, ischemia reperfusion injury, myocardial injury